LATENT VIEW ANALYTICS
|
LATENT VIEW ANALYTICS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.57 | 8.44 | 7.70 | 7.59 | 6.46 |
| CEPS(Rs) | 11.75 | 9.82 | 8.17 | 8.02 | 6.87 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 84.67 | 72.40 | 66.43 | 58.69 | 51.06 |
| Tax Rate(%) | 22.61 | 24.15 | 19.48 | 17.92 | 15.99 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 22.34 | 23.14 | 21.27 | 26.94 | 29.83 |
| EBIT Margin(%) | 25.62 | 27.82 | 31.27 | 35.66 | 38.49 |
| Pre Tax Margin(%) | 24.63 | 26.98 | 30.75 | 35.15 | 37.69 |
| PAT Margin (%) | 19.06 | 20.46 | 24.76 | 28.85 | 31.67 |
| Cash Profit Margin (%) | 22.93 | 23.92 | 26.27 | 30.49 | 33.66 |
| Performance Ratios | |||||
| ROA(%) | 10.44 | 10.73 | 11.80 | 13.41 | 16.57 |
| ROE(%) | 12.45 | 12.12 | 12.34 | 13.97 | 17.75 |
| ROCE(%) | 16.69 | 16.41 | 15.51 | 17.19 | 21.17 |
| Asset Turnover(x) | 0.55 | 0.52 | 0.48 | 0.46 | 0.52 |
| Sales/Fixed Asset(x) | 2.23 | 3.24 | 10.92 | 10.41 | 8.68 |
| Working Capital/Sales(x) | 1.41 | 1.13 | 0.63 | 0.59 | 0.48 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.45 | 0.31 | 0.09 | 0.10 | 0.12 |
| Receivable days | 71.60 | 64.13 | 60.29 | 61.73 | 64.53 |
| Inventory Days | - | - | - | - | - |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 26.24 | 43.53 | 65.95 | 42.40 | 65.39 |
| PCE(x) | 21.39 | 37.38 | 62.16 | 40.13 | 61.52 |
| Price/Book(x) | 2.97 | 5.07 | 7.65 | 5.48 | 8.28 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 4.59 | 8.83 | 15.68 | 11.23 | 19.07 |
| EV/Core EBITDA(x) | 15.56 | 28.22 | 47.84 | 30.11 | 54.40 |
| EV/EBIT(x) | 17.91 | 31.73 | 50.15 | 31.49 | 49.40 |
| EV/CE(x) | 2.77 | 4.99 | 7.31 | 5.01 | 7.24 |
| M Cap / Sales | 4.90 | 8.94 | 16.33 | 12.23 | 20.77 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 25.05 | 32.33 | 18.92 | 32.11 | 33.33 |
| Core EBITDA Growth(%) | 17.89 | 26.28 | 4.51 | 40.55 | 14.00 |
| EBIT Growth(%) | 15.18 | 17.73 | 4.28 | 22.04 | 32.81 |
| PAT Growth(%) | 16.50 | 9.36 | 2.07 | 20.01 | 41.60 |
| EPS Growth(%) | 13.50 | 9.49 | 1.57 | 17.39 | -94.25 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 4.05 | 6.64 | 20.04 | 27.75 | 18.08 |
| Quick Ratio(x) | 4.05 | 6.64 | 20.04 | 27.75 | 18.08 |
| Interest Cover(x) | 25.88 | 33.13 | 60.60 | 69.86 | 48.41 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of LATENT VIEW ANALYTICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LATENT VIEW ANALYTICS | ₹5,829.4 Cr | -3.1% | -9.4% | -29.1% | Stock Analytics | |
| PRIME FOCUS | ₹22,004.3 Cr | 1.4% | -3.6% | 90.2% | Stock Analytics | |
| SAGILITY | ₹19,951.8 Cr | -0.5% | 1.4% | -3.4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,959.1 Cr | -1.1% | -4.2% | -37.9% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,509.8 Cr | -2% | -1.3% | 4.2% | Stock Analytics | |
| INDEGENE | ₹13,636.2 Cr | -0.9% | 11.1% | -1.3% | Stock Analytics | |
LATENT VIEW ANALYTICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LATENT VIEW ANALYTICS | -3.1% |
-9.4% |
-29.1% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses
